Mr. Hunter brings more than 40 years of experience building and leading commercial organizations in the biopharmaceutical ...

FORM 8.3 The naming of nominee or vehicle companies is insufficient. For a trust, the trustee (s), settlor and beneficiaries must be named.

Adjusted EBITDA loss improved by 49% YoY to US$(3.3) million <li /> Improving revenue mix with high-margin insurance and wealth revenue ...